Corient Private Wealth’s ATAI Life Sciences ATAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-49,085
| Closed | -$56.9K | – | 2360 |
|
|
2024
Q3 | $56.9K | Buy |
49,085
+18,585
| +61% | +$21.6K | ﹤0.01% | 2347 |
|
|
2024
Q2 | $40.6K | Buy |
30,500
+11,815
| +63% | +$15.7K | ﹤0.01% | 2267 |
|
|
2024
Q1 | $36.8K | Sell |
18,685
-28,000
| -60% | -$55.2K | ﹤0.01% | 2232 |
|
|
2023
Q4 | $65.8K | Sell |
46,685
-5,200
| -10% | -$7.33K | ﹤0.01% | 2181 |
|
|
2023
Q3 | $66.9K | Buy |
51,885
+21,285
| +70% | +$27.5K | ﹤0.01% | 2058 |
|
|
2023
Q2 | $52.6K | Sell |
30,600
-20,400
| -40% | -$35.1K | ﹤0.01% | 2003 |
|
|
2023
Q1 | $92.3K | Buy |
51,000
+36,250
| +246% | +$65.6K | ﹤0.01% | 1882 |
|
|
2022
Q4 | $39.2K | Buy |
+14,750
| New | +$39.2K | ﹤0.01% | 1637 |
|